Clinitech Laboratory Ltd Management Discussions

Economy

Global Economic Review:

During the financial year 2025-26, the global economy demonstrated resilience despite continued geopolitical tensions, elevated trade policy uncertainty, and supply chain disruptions. Growth was supported by easing monetary conditions in several economies, improving labour markets, and sustained investment in technology and infrastructure. However, ongoing geopolitical conflicts, tariff-related uncertainties, and fluctuations in energy prices moderated the pace of global economic expansion.

According to the International Monetary Fund (IMF), global economic growth is estimated at around 3.1% during CY 2026, with a gradual improvement expected thereafter, supported by easing financial conditions and technological investments. Inflationary pressures remained relatively contained in several advanced economies, although commodity price volatility and geopolitical developments continue to pose downside risks.

While the global outlook remains positive over the medium term, risks arising from geopolitical conflicts, protectionist trade measures, climate-related events, and disruptions to global supply chains may continue to impact economic activity. Nevertheless, continued policy support by governments and central banks, coupled with increasing investments in digital technologies and artificial intelligence, are expected to sustain global growth momentum.

Indian Economic Review:

India continued to remain one of the fastest-growing major economies during FY 2025-26, supported by strong domestic demand, resilient consumption, healthy government capital expenditure, and sustained investments across infrastructure, manufacturing, healthcare and digital sectors.

The Indian economy is estimated to have grown by approximately 6.5%-6.6% during FY 2025- 26, despite external headwinds. Inflation remained within the Reserve Bank of Indias tolerance band for most of the year, supported by prudent monetary policy and easing food inflation, thereby strengthening consumer confidence and supporting private consumption.

Government initiatives under the National Infrastructure Pipeline, PM Gati Shakti, Digital India, Make in India, and Production Linked Incentive (PLI) schemes continued to stimulate investment and improve Indias business environment. Robust foreign investment inflows, increasing formalisation of the economy, rapid digital adoption, and growing healthcare expenditure further strengthened Indias economic fundamentals.

Going forward, the Indian economy is expected to continue its growth trajectory, driven by favourable demographics, increasing urbanisation, rising disposable incomes, expanding digital infrastructure, and continued policy support from the Government.

> Indian Diagnostic and healthcare service industry

The Indian diagnostic industry continues to be one of the fastest-growing segments of the healthcare sector and remains an indispensable pillar of the countrys healthcare ecosystem. Diagnostic laboratories play a vital role in disease detection, preventive healthcare, treatment planning and continuous patient monitoring.

The industry continued to witness healthy growth during FY 2025-26, supported by increasing health awareness, higher incidence of lifestyle-related and chronic diseases, an ageing population, expanding health insurance coverage, and rising demand for preventive healthcare.

Rapid technological advancements including laboratory automation, Artificial Intelligence (AI), digital pathology, molecular diagnostics, cloud-based laboratory information systems, and telemedicine integration are significantly improving diagnostic accuracy, operational efficiency and patient convenience.

Government initiatives such as Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB- PMJAY), Ayushman Bharat Digital Mission (ABDM), expansion of public healthcare infrastructure, and increasing digital health adoption continue to strengthen the diagnostic ecosystem. The integration of digital health records and technology-enabled healthcare delivery is expected to improve accessibility and quality of diagnostic services across the country.

India continues to enjoy a significant competitive advantage owing to its cost-effective diagnostic services, expanding network of laboratories, increasing investments in healthcare infrastructure, and growing medical tourism. These factors are expected to support sustained long-term growth of the diagnostic industry.

> Opportunities:

Demographic Advantage:

Indias large and growing population, coupled with increasing life expectancy and a rapidly expanding elderly population, is expected to generate sustained demand for diagnostic services. The rising prevalence of chronic diseases among individuals above 40 years of age further increases the need for regular diagnostic testing and health monitoring.

Rising Healthcare Awareness:

Increasing awareness regarding preventive healthcare, early disease detection and regular health screening is encouraging individuals to undergo routine diagnostic tests. Corporate wellness programmes and health check-up packages are also contributing to higher demand.

Growing Disposable Income:

Steady growth in disposable incomes and improving standards of living are enabling consumers to spend more on quality healthcare services, including advanced diagnostic testing and specialised investigations.

Expansion of Healthcare Infrastructure:

Rapid expansion of hospitals, clinics, diagnostic centres and healthcare facilities across Tier II and Tier III cities presents significant opportunities for organised diagnostic service providers to expand their presence and reach underserved markets.

Technological Advancement:

Adoption of automation, Artificial Intelligence, molecular diagnostics, digital pathology and integrated laboratory management systems is improving operational efficiency, reducing turnaround time and enhancing diagnostic accuracy, thereby creating new avenues for growth.

Preventive Healthcare:

Growing emphasis on preventive healthcare and wellness, coupled with increasing incidence of lifestyle diseases, is expected to drive long-term demand for preventive health packages and routine diagnostic screening.

> Threats:

Pricing Regulations:

Any regulatory intervention involving price caps or standardisation of diagnostic test pricing could adversely affect profitability and operating margins of diagnostic service providers.

Government Healthcare Initiatives:

Expansion of free or subsidised diagnostic services through Government hospitals and public healthcare schemes may intensify competition for private diagnostic laboratories in certain market segments.

Increasing Competition:

The Indian diagnostic industry continues to witness increasing competition from organised diagnostic chains, hospital-based laboratories, regional players and technology-enabled healthcare startups. Aggressive pricing strategies and expansion by competitors may impact market share and profitability.

Technological Disruption:

Rapid advancements in diagnostic technologies require continuous investment in modern equipment, automation and skilled manpower. Failure to keep pace with technological developments may impact competitiveness.

Regulatory Compliance:

The healthcare industry remains highly regulated. Changes in healthcare regulations, quality standards, accreditation requirements, data privacy norms and clinical protocols could increase compliance costs and operational complexity.

> Changes In Key Financial Ratios:

Pursuant to provisions of Regulation 34 (3) of SEBI (LODR) Regulation, 2015 read with Schedule V part B(1) details of changes in Key Financial Ratios is given hereunder:

Sr. No.	Key Financial Ratio	FY 2025-26	FY 2024-25
1.	Debtors Turnover Ratio	5.13	5.34
2.	Inventory Turnover Ratio	15.05	20.26
3.	Interest Coverage Ratio	12.34	13.96
4.	Current Ratio	7.04	4.12
5.	Debt Equity Ratio	0.04	-
6.	Operation Profit Margin	10.5	10.1
7.	Net Profit Margin	4.46	4.79
8.	Change in Return on Net Worth	4.57	4.47

*Previous years Figures have been regrouped / rearranged wherever necessary

> Risks and concerns:

The Company operates in a dynamic healthcare and diagnostic services environment and is exposed to various business risks including regulatory changes, technological advancements, pricing pressures, increased competition, cybersecurity risks, and fluctuations in operating costs. The Board of Directors periodically reviews the risk management framework to identify, assess and mitigate potential risks that may affect the Companys operations and performance.

The Company continues to strengthen its operational processes through the adoption of advanced diagnostic technologies, laboratory automation, digital solutions and robust quality control mechanisms. Continuous investments in infrastructure, information technology systems, data security and process improvements help the Company enhance operational efficiency, ensure optimum utilization of resources and maintain high standards of service quality. The Company also focuses on compliance with applicable regulatory requirements and industry standards to safeguard its long-term sustainability and growth.

> Health, safety and Security Environment:

The Company remains committed to providing a safe, secure and healthy working environment for all its employees, healthcare professionals and other stakeholders. Stringent safety protocols, infection control practices, quality assurance measures and occupational health standards are implemented across all operational locations to ensure the well-being of employees and patients.

Regular training programmes, awareness initiatives and safety audits are conducted to strengthen the culture of workplace safety and regulatory compliance. The Company continues to invest in modern laboratory equipment, secure information systems and process enhancements to ensure operational reliability, patient confidentiality and data security.

As a responsible healthcare service provider, the Company remains dedicated to maintaining the highest ethical standards and delivering accurate, reliable and timely diagnostic services that contribute to improved healthcare outcomes.

> Human Resources/Industrial Relations:

Human resources continue to be one of the Companys most valuable assets. The Company believes that its sustained growth and success depend significantly on the commitment, competence and dedication of its employees.

During the financial year 2025-26, industrial relations across all locations of the Company remained cordial and harmonious. The Company continued to focus on employee development through various training and skill enhancement programmes aimed at improving professional capabilities, productivity, service quality and operational effectiveness.

The Company also emphasizes employee engagement, workplace diversity, performance management and a positive work culture that encourages innovation, collaboration and continuous learning. Appropriate measures are regularly undertaken to enhance employee well- being, motivation and retention, thereby contributing to the achievement of the Companys strategic objectives.

> Cautionary Statement:

Statements contained in this Management Discussion and Analysis Report describing the Companys objectives, projections, estimates, expectations, plans or predictions may constitute "forward-looking statements" within the meaning of applicable laws and regulations.

Actual results may differ materially from those expressed or implied in such statements due to various factors including changes in economic conditions, government policies, regulatory developments, competitive pressures, technological changes, market conditions and other risks and uncertainties beyond the Companys control.

The Company assumes no responsibility to publicly amend, modify or revise any forward-looking statements based on subsequent developments, information or events except as required under applicable laws and regulations.

	For & on behalf of the Board of Directors of
	Clinitech Laboratory Limited
	Sd/-	Sd/-
	Jagdish Umakant Nayak	Jyoti Jagdish Nayak
	Managing Director	Whole-time Director
	DIN: 00646672	DIN: 02945625
Place: Navi Mumbai
Date: 17th August, 2026